Suppr超能文献

胰腺分裂继发慢性胰腺炎患者内镜支架置入的长期随访

Long-term follow-up of endoscopic stenting in patients with chronic pancreatitis secondary to pancreas divisum.

作者信息

Vitale Gary C, Vitale Michael, Vitale David S, Binford John C, Hill Ben

机构信息

Department of Surgery, University of Louisville School of Medicine, Louisville, KY 40292, USA.

出版信息

Surg Endosc. 2007 Dec;21(12):2199-202. doi: 10.1007/s00464-007-9347-0. Epub 2007 May 19.

Abstract

BACKGROUND

Pancreas divisum is the most common anatomic variant of pancreatic development and may lead to pancreatitis. This study evaluated the efficacy of endoscopic stenting in patients with chronic pancreatitis due to pancreas divisum.

METHODS

Between 1993 and 2005, 32 patients with chronic pancreatitis due to pancreas divisum were treated with endoscopic stenting. Each patient underwent an endoscopic retrograde cholangiopancreatography to confirm the diagnosis of pancreas divisum prior to endoscopic stenting. A survey was conducted by telephone conversation to evaluate pain intensity, symptom relief, hospital admissions, quality of life and pain medication usage, which was verified by a statewide narcotic electronic database. Eight of the 32 patients were unavailable for the interview and were not included in the analysis of the study. Results are expressed as mean +/- standard error of the mean (SEM).

RESULTS

Twenty-four patients were followed up for a period of 59.6 months. The overall pain level average in the 24 patients decreased significantly from 8.9 +/- 0.4 pre-stenting to 3.9 +/- 0.7 post-stenting (P < 0.05) on a scale of 1 to 10. The number of hospital admissions per year in these patients decreased significantly from 7.3 +/- 2.1 pre-stenting to 2.1 +/- 0.4 post-stenting (P < 0.05). Pain medication usage reported by the patients found a decrease in 58% of patients, 21% remained the same, and 13% increased their usage. There was improvement in nausea (67%), vomiting (63%), and chronic pain (75%). Thirteen patients (55%) were treated endoscopically without requiring surgery and 11 (45%) patients required surgery after stenting. These 11 patients had surgery an average of 25 months post-stenting. The complication rate of post-procedural pancreatitis was 3.4%. No mortality was reported in this study.

CONCLUSION

Endoscopic stenting of the pancreatic duct is a safe and effective first treatment for patients with pancreatitis secondary to pancreas divisum. Surgery, when performed for endoscopic stenting failure, is effective as an adjunctive treatment.

摘要

背景

胰腺分裂是胰腺发育最常见的解剖变异,可能导致胰腺炎。本研究评估了内镜支架置入术对胰腺分裂所致慢性胰腺炎患者的疗效。

方法

1993年至2005年期间,32例胰腺分裂所致慢性胰腺炎患者接受了内镜支架置入术治疗。每位患者在内镜支架置入术前均接受了内镜逆行胰胆管造影术以确诊胰腺分裂。通过电话访谈进行调查,以评估疼痛强度、症状缓解情况、住院次数、生活质量和止痛药物使用情况,并通过全州麻醉药品电子数据库进行核实。32例患者中有8例无法接受访谈,未纳入本研究分析。结果以平均值±平均标准误差(SEM)表示。

结果

24例患者接受了59.6个月的随访。这24例患者的总体疼痛水平平均从支架置入术前的8.9±0.4显著降至支架置入术后的3.9±0.7(P<0.05),疼痛程度采用1至10分制。这些患者每年的住院次数从支架置入术前的7.3±2.1显著降至支架置入术后的2.1±0.4(P<0.05)。患者报告的止痛药物使用情况显示,58%的患者用药量减少,21%的患者用药量不变,13%的患者用药量增加。恶心(67%)、呕吐(63%)和慢性疼痛(75%)均有改善。13例患者(55%)经内镜治疗无需手术,11例(45%)患者在支架置入术后需要手术。这11例患者在支架置入术后平均25个月接受了手术。术后胰腺炎的并发症发生率为3.4%。本研究未报告死亡病例。

结论

胰管内镜支架置入术是胰腺分裂继发胰腺炎患者安全有效的首选治疗方法。对于内镜支架置入术失败而进行的手术,作为辅助治疗是有效的。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验